Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedMay 26, 2021Asenapine Sublingual TabletsIncorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agentSigmaPharm Laboratories LLC · D-0379-2021Class IITerminatedMay 26, 2021Haloperidol Decanoate InjectionLack of Assurance of SterilityTeva Pharmaceuticals USA · D-0378-2021Class IITerminatedMay 26, 2021Metoclopramide Injection USPLack of Assurance of SterilityTeva Pharmaceuticals USA · D-0377-2021Class IITerminatedMay 26, 2021Methylprednisolone Acetate Injectable Suspension USPLack of Assurance of SterilityTeva Pharmaceuticals USA · D-0376-2021Class IITerminatedMay 26, 2021Haloperidol Decanoate InjectionLack of Assurance of SterilityTeva Pharmaceuticals USA · D-0375-2021Class IITerminatedMay 26, 2021Leucovorin Calcium for InjectionLack of Assurance of SterilityTeva Pharmaceuticals USA · D-0374-2021Class ITerminatedMay 19, 2021BD ChloraPrep Hi-Lite Orange 26 mL ApplicatorDefective Delivery System: An increase in complaints identified endcap being loose or falling off upon activation releasing glass shards containing the solution.CareFusion 213, LLC · D-0373-2021Class IITerminatedMay 19, 2021Metformin HCl Extended-Release TabletsPresence of foreign substance: identified as activated carbon.Sun Pharmaceutical Industries Inc · D-0372-2021Class IIOngoingMay 12, 2021Imperial Platinum 2000Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.QMart · D-0371-2021Class IIOngoingMay 12, 2021Burro en PrimaveraMarketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.QMart · D-0370-2021Class IIOngoingMay 12, 2021PremierZen Extreme 3000Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.QMart · D-0369-2021Class IIOngoingMay 12, 2021IMPERIAL GOLD 2000Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.QMart · D-0368-2021Class IIITerminatedMay 12, 2021Acyclovir TabletsLabeling: Incorrect or Missing Lot and/or Exp DateHeritage Pharmaceuticals Inc · D-0367-2021Class IITerminatedMay 12, 2021Thumbs Up 7 Red 70KMarketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.Antoto-K · D-0366-2021Class ITerminatedMay 12, 2021heal the worldLabeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.Pnhc, LLC. · D-0365-2021Class ITerminatedMay 12, 2021AcetaminophenLabeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 count, included in Health Essential Kits, labeled incorrectly with a...A-S Medication Solutions LLC. · D-0358-2021Class IIITerminatedMay 5, 2021EvrysdiDefective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot...Genentech Inc · D-0357-2021Class IITerminatedMay 5, 2021Oxygen, CompressedcGMP deviationsGrace Healthcare Medical, Inc · D-0355-2021Class IIOngoingMay 5, 2021Triple SupremeZen Gold 3500Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.Na Na Collection · D-0354-2021Class IIOngoingMay 5, 2021PremierZen Platinum 5000Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.Na Na Collection · D-0353-2021Class IIOngoingMay 5, 2021Imperial Extreme 2000 CapsulesMarketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.S & B Story LLC · D-0352-2021Class IITerminatedMay 5, 2021PremierZen Black 5000 capsulesMarketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.Namoo Enterprise LLC · D-0351-2021Class IITerminatedMay 5, 2021ChloraPrep With Tint 2% w/v chlorhexidine gluconateCGMP Deviations: Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus...CareFusion 213, LLC · D-0350-2021Class IITerminatedMay 5, 2021ChloraPrep One-Step 2% w/v chlorhexidine gluconateCGMP Deviations: Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus...CareFusion 213, LLC · D-0349-2021Class IITerminatedMay 5, 2021BD ChloraPrep Hi-Lite Orange 2% w/v chlorhexidine gluconateLack of Assurance of Sterility: Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of...CareFusion 213, LLC · D-0348-2021Class IITerminatedMay 5, 2021BD ChloraPrep ClearLack of Assurance of Sterility: Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of...CareFusion 213, LLC · D-0347-2021Class ITerminatedMay 5, 2021ChloraPrep With Tint 2% w/v chlorhexidine gluconateMicrobial Contamination of Non-Sterile Product:.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus...CareFusion 213, LLC · D-0346-2021Class ITerminatedMay 5, 2021ChloraPrep One-Step 2% w/v chlorhexidine gluconateMicrobial Contamination of Non-Sterile Product.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus...CareFusion 213, LLC · D-0345-2021Class ITerminatedMay 5, 2021BD ChloraPrep Hi-Lite Orange 2% w/v chlorhexidine gluconateNon-sterility.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus...CareFusion 213, LLC · D-0344-2021Class ITerminatedMay 5, 2021BD ChloraPrep ClearNon-sterility.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus...CareFusion 213, LLC · D-0343-2021Class IIOngoingMay 5, 2021Cephalexin for Oral SuspensionFailed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during...Preferred Pharmaceuticals, Inc. · D-0342-2021Class IITerminatedMay 5, 2021Losartan Potassium USPCGMP deviation: Product found to contain trace amounts of NMBAPD-Rx Pharmaceuticals, Inc. · D-0341-2021Class IIITerminatedMay 5, 2021Betamethasone Dipropionate Ointment USPFailed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.Teligent Pharma, Inc. · D-0340-2021Class IIITerminatedMay 5, 2021Betamethasone Dipropionate Ointment USPFailed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.Teligent Pharma, Inc. · D-0339-2021Class IIITerminatedMay 5, 2021Betamethasone Dipropionate Ointment USPFailed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.Teligent Pharma, Inc. · D-0338-2021Class IIOngoingApr 28, 2021Flurandrenolide Ointment USPFailed Impurities/Degradation Specifications:Teligent Pharma, Inc. · D-0356-2021Class IITerminatedApr 28, 2021Estradiol Transdermal System Delivers 0.0375 mg/dayDefective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a...Noven Pharmaceuticals Inc · D-0337-2021Class IITerminatedApr 28, 2021MinivelleDefective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a...Noven Pharmaceuticals Inc · D-0336-2021Class IITerminatedApr 28, 2021BetadineDefective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterilityEdge Pharma, LLC · D-0335-2021Class ITerminatedApr 21, 2021Xultophy 100/3.6Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and...Novo Nordisk Inc · D-0623-2021